Baby Safety / Compounds / Moxidectin

Is Moxidectin safe for babies and kids?

Context-dependent for kids

(Babies-specific data is limited; this page draws from human pregnant context.) Pregnancy alters the metabolism and distribution of Moxidectin, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

What is moxidectin?

CAS number
113507-06-5
Molecular formula
C37H53NO8
Molecular weight
639.82 g/mol
SMILES
CC1CC=CC(CC(OC2CC(CC3(CC(C(C(O3)CC(C(C4C(CC(O4)C(CC=CC=CC=C1)C)C)O)C)O)O)C)OC)C)(C)O
PubChem CID
9832750

Risk for babies

Context-dependent

Pregnancy alters the metabolism and distribution of Moxidectin, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Moxidectin, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

1 regulatory bodyhas classified Moxidectin.

AgencyYearClassificationNotes
FDA1997Approved vet (NADA 141-189) + human drug (NDA 210867)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter moxidectin

  • Veterinary Medicine

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Moxidectin:

  • Ivermectin (lower cost)
    Trade-offs: Alternative approach; specific tradeoffs depend on application context, scale, and regulatory requirements. Full hazard assessment of alternative recommended before adoption to avoid regrettable substitution.
    Relative cost: 1.2-2×
  • Selamectin (topical)
    Trade-offs: Alternative approach; specific tradeoffs depend on application context, scale, and regulatory requirements. Full hazard assessment of alternative recommended before adoption to avoid regrettable substitution.
    Relative cost: 1.2-2×

Frequently asked questions

No FAQ entries generated.

See Moxidectin in the baby app

Look up products containing moxidectin, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)
  1. —

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →